ATE440100T1 - Prenyl transferasinhibitoren - Google Patents
Prenyl transferasinhibitorenInfo
- Publication number
- ATE440100T1 ATE440100T1 AT03078315T AT03078315T ATE440100T1 AT E440100 T1 ATE440100 T1 AT E440100T1 AT 03078315 T AT03078315 T AT 03078315T AT 03078315 T AT03078315 T AT 03078315T AT E440100 T1 ATE440100 T1 AT E440100T1
- Authority
- AT
- Austria
- Prior art keywords
- prenyl
- transferas
- inhibitors
- chem
- bond
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 102000019337 Prenyltransferases Human genes 0.000 abstract 1
- 108050006837 Prenyltransferases Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11430198P | 1998-12-31 | 1998-12-31 | |
| US22442898A | 1998-12-31 | 1998-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE440100T1 true ATE440100T1 (de) | 2009-09-15 |
Family
ID=26812031
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03078315T ATE440100T1 (de) | 1998-12-31 | 1999-12-30 | Prenyl transferasinhibitoren |
| AT99968984T ATE261447T1 (de) | 1998-12-31 | 1999-12-30 | Prenyltransferase-inhibitoren |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99968984T ATE261447T1 (de) | 1998-12-31 | 1999-12-30 | Prenyltransferase-inhibitoren |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7361656B2 (de) |
| EP (2) | EP1382607B1 (de) |
| AT (2) | ATE440100T1 (de) |
| AU (1) | AU2717100A (de) |
| CA (1) | CA2356756A1 (de) |
| CZ (1) | CZ20012358A3 (de) |
| DE (2) | DE69941307D1 (de) |
| DK (1) | DK1140942T3 (de) |
| ES (2) | ES2215420T3 (de) |
| HU (1) | HUP0104708A3 (de) |
| NO (1) | NO321057B1 (de) |
| PT (1) | PT1140942E (de) |
| RU (1) | RU2241712C9 (de) |
| WO (1) | WO2000039130A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2812546B1 (fr) * | 2000-08-01 | 2008-11-21 | Sod Conseils Rech Applic | Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments |
| TWI283577B (en) * | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
| EP1542691B1 (de) * | 2002-09-27 | 2009-01-07 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben |
| JP5342450B2 (ja) * | 2006-12-15 | 2013-11-13 | ブリストル−マイヤーズ スクイブ カンパニー | 第ＸＩａ因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ |
| TWI421252B (zh) * | 2009-07-09 | 2014-01-01 | Irm Llc | 用於治療寄生蟲疾病之化合物及組合物 |
| EP2508511A1 (de) | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitoren der Virenreplikation, Verfahren zu deren Herstellung und deren therapeutische Verwendung |
| DK2925745T3 (en) * | 2012-11-29 | 2018-07-23 | Chemocentryx Inc | CXCR7 antagonists |
| CN106317057B (zh) * | 2015-07-02 | 2019-02-01 | 北京桦冠医药科技有限公司 | 具有咪唑并吡嗪类衍生物，其制备及其在医药上的应用 |
| EP3615030A1 (de) | 2017-04-24 | 2020-03-04 | Novartis AG | Therapeutisches dosierschema von 2-amino-l-(2-(4-fluorphenyl)-3-(4-fluorphenylamino)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8h)-yl)ethanon und kombinationen davon |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990010631A1 (en) * | 1989-02-27 | 1990-09-20 | Biocryst | 9-substituted-8-unsubstituted-9-deazaguanines |
| RU2092487C1 (ru) * | 1992-04-24 | 1997-10-10 | Ньюроджен Корпорейшн | Имидазохиноксалины |
| WO1994026723A2 (en) * | 1993-05-14 | 1994-11-24 | Genentech, Inc. | ras FARNESYL TRANSFERASE INHIBITORS |
| US5488109A (en) | 1993-11-05 | 1996-01-30 | Dowelanco | 5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3H)--thione compounds and their use in the preparation of and 2-chlorosulfonyl-5-alkoxy[1,2,4]triazolo[1,5-c]-pyrimidine compounds |
| US5488189A (en) * | 1993-12-14 | 1996-01-30 | E. I. Du Pont De Nemours And Company | Process for fluorinated propanes and pentanes |
| US6673927B2 (en) * | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
| FR2780974B1 (fr) * | 1998-07-08 | 2001-09-28 | Sod Conseils Rech Applic | Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique |
| UA74912C2 (en) * | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
-
1999
- 1999-12-30 DE DE69941307T patent/DE69941307D1/de not_active Expired - Lifetime
- 1999-12-30 RU RU2001121317/04A patent/RU2241712C9/ru not_active IP Right Cessation
- 1999-12-30 EP EP03078315A patent/EP1382607B1/de not_active Expired - Lifetime
- 1999-12-30 AT AT03078315T patent/ATE440100T1/de not_active IP Right Cessation
- 1999-12-30 EP EP99968984A patent/EP1140942B1/de not_active Expired - Lifetime
- 1999-12-30 PT PT99968984T patent/PT1140942E/pt unknown
- 1999-12-30 HU HU0104708A patent/HUP0104708A3/hu unknown
- 1999-12-30 AT AT99968984T patent/ATE261447T1/de not_active IP Right Cessation
- 1999-12-30 AU AU27171/00A patent/AU2717100A/en not_active Abandoned
- 1999-12-30 WO PCT/US1999/031302 patent/WO2000039130A2/en not_active Ceased
- 1999-12-30 DK DK99968984T patent/DK1140942T3/da active
- 1999-12-30 CZ CZ20012358A patent/CZ20012358A3/cs unknown
- 1999-12-30 CA CA002356756A patent/CA2356756A1/en not_active Abandoned
- 1999-12-30 ES ES99968984T patent/ES2215420T3/es not_active Expired - Lifetime
- 1999-12-30 DE DE69915514T patent/DE69915514T2/de not_active Expired - Lifetime
- 1999-12-30 ES ES03078315T patent/ES2328564T3/es not_active Expired - Lifetime
-
2001
- 2001-06-29 NO NO20013281A patent/NO321057B1/no unknown
-
2006
- 2006-02-14 US US11/353,518 patent/US7361656B2/en not_active Expired - Fee Related
-
2007
- 2007-10-30 US US11/929,118 patent/US7691859B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO20013281D0 (no) | 2001-06-29 |
| EP1382607A2 (de) | 2004-01-21 |
| HUP0104708A2 (hu) | 2002-04-29 |
| US7361656B2 (en) | 2008-04-22 |
| ATE261447T1 (de) | 2004-03-15 |
| EP1382607A3 (de) | 2004-06-30 |
| NO20013281L (no) | 2001-08-29 |
| DK1140942T3 (da) | 2004-05-24 |
| AU2717100A (en) | 2000-07-31 |
| EP1382607B1 (de) | 2009-08-19 |
| EP1140942B1 (de) | 2004-03-10 |
| WO2000039130A2 (en) | 2000-07-06 |
| CZ20012358A3 (cs) | 2002-01-16 |
| DE69915514D1 (de) | 2004-04-15 |
| EP1140942A2 (de) | 2001-10-10 |
| CA2356756A1 (en) | 2000-07-06 |
| DE69915514T2 (de) | 2005-01-05 |
| US7691859B2 (en) | 2010-04-06 |
| NO321057B1 (no) | 2006-03-06 |
| RU2241712C9 (ru) | 2006-04-20 |
| ES2215420T3 (es) | 2004-10-01 |
| US20060142275A1 (en) | 2006-06-29 |
| DE69941307D1 (de) | 2009-10-01 |
| WO2000039130A3 (en) | 2000-11-02 |
| HUP0104708A3 (en) | 2004-05-28 |
| PT1140942E (pt) | 2004-05-31 |
| RU2241712C2 (ru) | 2004-12-10 |
| US20080176835A1 (en) | 2008-07-24 |
| ES2328564T3 (es) | 2009-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0976748A4 (de) | Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben | |
| DK0931788T3 (da) | Metalloproteasehæmmere | |
| DK1022272T3 (da) | Substituerede, fusionerede, heterocykliske forbindelser | |
| MY136141A (en) | Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors | |
| ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
| DK1265606T3 (da) | Celleadhæsionsinhibitorer | |
| GB9625045D0 (en) | Parasiticidal compounds | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
| DK0791007T3 (da) | Antifungale sordaridinderivater | |
| ATE440100T1 (de) | Prenyl transferasinhibitoren | |
| ATE232528T1 (de) | Pyrimidinylpyrazolderivate | |
| BRPI0411664A (pt) | composição oral antiplaca aquosa estável | |
| TH25178A (th) | สารประกอบประเภทใหม่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |